Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Utah Medical Products (UTMD) Shares Outstanding (2016 - 2025)

Utah Medical Products has reported Shares Outstanding over the past 16 years, most recently at $3.2 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $3.2 million for Q4 2025, down 4.47% from a year ago — trailing twelve months through Dec 2025 was $3.2 million (down 4.47% YoY), and the annual figure for FY2025 was $3.2 million, down 4.47%.
  • Shares Outstanding for Q4 2025 was $3.2 million at Utah Medical Products, down from $3.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for UTMD hit a ceiling of $3.7 million in Q4 2021 and a floor of $3.2 million in Q4 2025.
  • Median Shares Outstanding over the past 5 years was $3.6 million (2022), compared with a mean of $3.5 million.
  • Biggest five-year swings in Shares Outstanding: increased 0.33% in 2021 and later fell 8.56% in 2025.
  • Utah Medical Products' Shares Outstanding stood at $3.7 million in 2021, then dropped by 0.74% to $3.6 million in 2022, then increased by 0.06% to $3.6 million in 2023, then decreased by 8.13% to $3.3 million in 2024, then decreased by 4.47% to $3.2 million in 2025.
  • The last three reported values for Shares Outstanding were $3.2 million (Q4 2025), $3.2 million (Q3 2025), and $3.2 million (Q2 2025) per Business Quant data.